An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
Clinical trial NCT06832410 · RECRUITING
Trial details
- NCT number
- NCT06832410
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-31
- Primary completion
- 2026-09-17
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.